Wockhardt Zaynich successfully treats paediatric cancer patient with recalcitrant blood, liver infection Ruchika Sharma1 April 2025 12:15 PM ISTThe patient was treated with Zaynich for 41 days, resulting in the successful resolution of the infection.
Zaynich shows over 97 percent efficacy for drug-resistant bacteria: Wockhardt Ruchika Sharma13 Jan 2025 1:06 PM ISTMumbai: Wockhardt has announced that Zaynich (Zidebactam/Cefepime, WCK 5222) demonstrated over 97 percent clinical efficacy in treating...
Role of Cefepime/Enmetazobactam in Ventilator-associated Pneumonia (VAP) Dr. Kamal Kant Kohli4 Nov 2024 11:00 AM ISTKey Takeaways:Ventilator-associated pneumonia (VAP) is the most common ICU infection, affecting up to 20% of critically ill patients with a mortality...
Role of Cefepime Enmetazobactam in HAP Dr. Kamal Kant Kohli25 Sept 2024 11:30 AM ISTKey Takeaways:Hospital-acquired pneumonia (HAP) is associated with significant morbidity, mortality, and increased healthcare costs.Common pathogens...
CDSCO Panel Approves Wockhardt's Protocol Amendment Proposal for antimicrobial drug Cefepime plus Zidebactam Dr. Divya Colin3 Sept 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Wockhardt's...
Orchid Pharma collaborates with Cipla to unveil antibiotic Cefepime-Enmetazobactam in India Ruchika Sharma29 Jun 2024 12:00 PM ISTNew Delhi: Orchid Pharma Limited, based in Chennai, India, the only Indian pharmaceutical company to have ever invented a New Chemical Entity...
DCGI nod to Orchid Pharma Antibiotic Drug Combination of Cefepime, Enmetazobactam (NCE) Ruchika Sharma6 Jun 2024 12:25 PM ISTNew Delhi: Chennai-based Pharma Company, Orchid Pharma, has received Drugs Controller General of India (DCGI) approval for the manufacturing and...
FDA approves Exblifep for complicated UTI including pyelonephritis Dr. Kamal Kant Kohli1 March 2024 11:30 PM ISTThe US Food and Drug Administration (FDA) has approved Exblifep (cefepime/enmetazobactam) for treatment of complicated urinary tract infections...
Cefepime-taniborbactam superior to meropenem in treating complicated UTIs and acute pyelonephritis: NEJM Aditi20 Feb 2024 7:15 AM ISTCarbapenem-resistant Enterobacterales species and multidrug-resistant Pseudomonas aeruginosa pose significant global health threats....
Wockhardt Gets CDSCO Panel Nod To study combination of cefepime and zidebactam. Dr. Divya Colin16 Jan 2024 5:00 PM ISTNew Delhi: The drug major Wockhardt has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel grants Wockhardt's Protocol Amendment Proposal For Cefepime Zidebactam Dr. Divya Colin11 Jan 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Wockhardt gets CDSCO Panel Nod to study antimicrobial FDC Cefepime plus Tazobactum Dr. Divya Colin26 Nov 2023 3:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted permission to the...
